The relationship between cytotoxicity and kinetics of cadmium uptake was investigated in primary rat hepatocyte cultures. Primary rat hepatocytes were exposed to cadmium concentrations ranging from 1.0 to 80 M in albumin-free buffer or 32 to 8000 M in buffer containing physiological concentrations of bovine serum albumin (600 M) for 1 h, and cellular toxicity was observed at 23 h postexposure. Hepatocytes exposed to cadmium in the presence of albumin appeared less sensitive to cadmium toxicity when compared to cells exposed in the absence of albumin. The experimentally derived 23-h postexposure EC 50 s for hepatocytes exposed to cadmium in both presence and absence of albumin was 65.5 ؎ 2.4 and 14.3 ؎ 3.9 M, respectively. A Scatchard plot of cadmium binding to albumin suggested two high-affinity binding sites. The observed uptake of cadmium by hepatocytes in the absence and presence of albumin consisted of a composite fast uptake rate and cell membrane association (Component I), and a slow, sustained uptake rate (Component II). Cadmium uptake rates in hepatocytes, based on total medium cadmium concentrations, indicated that Component II uptake rates were four times faster under albumin-free exposure conditions. However, when uptake rates were evaluated, based on the calculated equilibrium concentration of free cadmium in the exposure buffer, uptake rates in hepatocytes exposed in the presence of albumin were two times as fast. This faster cadmium uptake in the presence of albumin may result from diffusion-limited, nonequilibrium conditions occurring at the cell surface.
A critical component in the development of biologically based kinetic (BBK) models for estimating target organ dosimetry is the understanding of the uptake kinetics and accumulation of chemicals at the cellular level. These determinations are difficult or impossible to assess directly in vivo. Use of primary cultures of target organ cells in chemical kinetic studies offers a useful in vitro research tool to provide these data that can be integrated into BBK models to predict in vivo dosimetry of chemicals (Frazier, 1995) . However, it is important that these in vitro systems be well characterized so that accurate extrapolation to the in vivo situation can be made. Specifically, the effect of protein binding in culture medium must be quantitatively understood in order to extrapolate the uptake rate of chemical from the in vitro to the in vivo case.
The liver is the primary target organ following acute systemic cadmium (Cd 2ϩ ) exposure (Dudley et al., 1982) . Uptake of Cd 2ϩ into the liver is critical to the development of the overall toxicity induced by this heavy metal. Approximately half of the Cd 2ϩ absorbed systemically is rapidly accumulated in the liver of rats (Perry et al., 1970; Sasser and Jarboe, 1977) . This rapid accumulation by the liver results in reduced availability of Cd 2ϩ to other organs such as kidney and testes, which are more sensitive to its toxic actions.
Direct metabolic conversion of Cd 2ϩ , such as oxidation, reduction, or alkylation, is not known to exist. After entering the blood, Cd 2ϩ can bind to plasma proteins (albumin, globulins, etc.), metallothionein (Mt), or directly to erythrocytes. The divalent Cd 2ϩ ions bind to anionic groups on proteins and other molecules through charge interactions and with sulfhydryl groups through coordinate-covalent binding. Cadmium has a particularly high affinity for the sulfhydryl groups of albumin and Mt (Nordberg et al., 1985) . Therefore, Cd 2ϩ circulates in the blood primarily bound to albumin and traces of Mt (Foulkes and Blanck, 1990; Roberts and Clark, 1988) . Presumably, this affinity for protein sulfhydryl groups results in Cd 2ϩ binding to a multitude of cellular proteins, both within cells and on cell surfaces. Kingsley (1976, 1977) have shown using kinetic studies in the isolated perfused rat liver that the uptake of Cd 2ϩ by the liver involves a combination of simple diffusion and carrier mediated processes. Isolated hepatocytes have been used as a model for examining Cd 2ϩ kinetics and toxicity (Din and Frazier, 1985; . Cadmium uptake in isolated hepatocyte suspension and plated cultures has been shown to be rapid, biphasic, and energy-independent (Blazka and Shaikh, 1992; . However, these studies conducted Cd 2ϩ exposures under nonphysiological conditions with respect to plasma albumin concentrations. Furthermore, Cd 2ϩ uptake kinetics in freshly isolated suspension cultures have been shown to differ from those observed in primary cultures of rat hepatocytes (Kukongviriyapan and Stacey, 1989) . These differences are probably due to the compromised integrity of the plasma membrane during hepatocyte isolation (Gautum et al., 1987; Wanson et al., 1977) .
The objective of the present study was to investigate the effects of physiological concentrations of serum albumin (600 M) on the kinetics of Cd 2ϩ uptake in primary cultures of rat hepatocytes. Previous studies have shown that Cd 2ϩ can bind to plasma albumin from a variety of species (Suzuki et al., 1986; Nordberg and Nordberg, 1987) and to approximately the same extent (Goumakos et al., 1991) . The use of rat serum albumin (RSA) was considered, but limited availability and excessive cost made it not feasible to conduct a study of the magnitude planned. Based on these observations, and the fact that most previous work investigating Cd 2ϩ uptake kinetics in vitro were conducted utilizing bovine serum albumin (BSA) at nonphysiological concentrations, BSA was chosen as the source of albumin to conduct in vitro Cd 2ϩ uptake studies in primary hepatocytes exposed and cultured under more physiological conditions with respect to albumin concentration. The influence of albumin binding on the concentration of free Cd 2ϩ in tissue culture dosing buffer was investigated in independent binding studies. The binding data were used to interpret the uptake kinetics of Cd 2ϩ . These kinetic data are critical for the development of a BBK model for Cd 2ϩ to support accurate predictions of hepatic dosimetry in rats and to extrapolate this dosimetry estimate to humans. Animals. Male Fischer 344 rats (225-300 g) were obtained from Charles River Laboratories. Animals were fed rat chow (Purina) ad libitum and had unrestricted access to purified water. The animals used in this study were handled in accordance with the principles stated in the Guide for the Care and Use of Laboratory Animals, National Research Council, 1996 , and the Animal Welfare Act of 1966, as amended.
MATERIALS AND METHODS

Materials
Rat liver perfusion. Male Fischer 344 rats were anesthetized ip with 1 ml/kg of a mixture of ketamine (70 mg/ml; Parke-Davis, Moris Plains, NJ) and xylazine (6 mg/ml; Mobay Corp., Shawnee, KS) prior to undergoing the in situ liver perfusion. Livers were perfused at a flow rate of 20 ml/min at 37°C using an antigrade two-step perfusion method described by Seglen (1976) as previously modified (DelRaso and Frazier, 1999) . The first perfusion step resulted in blood removal from the liver using Hank's balanced salt solution (HBSS; pH 7.2), lacking calcium and magnesium, supplemented with 15 mM 4-(2-hydroxyethl)-1-piperazineethanesulfonic acid (HEPES), heparin (2.0 U/ml) and ethylenebis(oxyethylenenitrilo)-tetraacetic acid (EGTA; 0.5 mM). The second perfusion step resulted in liver digestion, using complete HBSS buffer (pH 7.2) supplemented with 15 mM HEPES and collagenase (0.26 U/ml; based on Wunsche U/mg).
Hepatocyte enrichment and culture. Viable primary rat hepatocytes were enriched from the crude hepatocyte suspension by low speed centrifugation (50 g) for 3 min, repeated three times. Typical viabilities of isolated hepatocytes ranged from 80 to 90% with yields of 200 to 300 million cells, as determined by trypan blue dye exclusion (Story et al., 1983) . For cell culture studies, primary hepatocytes (2 to 3 ϫ 10 8 cells) were adjusted to a cell density of 1.2 ϫ 10 6 cell/ml in Chee modified MEM culture medium (pH 7.2; Gibco, Grand Island, NY) supplemented with HEPES (10 mM), insulin/transferrin/ sodium selenite solution (final concentration 5 g/ml, 5 g/ml, and 5 ng/ml, respectively) and dexamethasone (0.4 mg/ml). For all Cd 2ϩ uptake studies, 1.0 ml of cells was seeded in 6-well (1.2 ϫ 10 6 cells/well) culture plates previously coated with rat tail collagen (Upstate Biotechnology, Lake Placid, NY) at 2.6 mg/cm 2 . After 3 h of incubation in a 95% air/5% CO 2 atmosphere at 37°C, to allow for attachment, rat hepatocytes were re-fed with 2.0 ml of Chee culture medium lacking dexamethasone. Hepatocytes were cultured and treated according to the experimental schedule outlined in Figure 1 .
Biochemical Assays
MTT assay. Cell viability in plated primary rat hepatocyte cultures was determined spectrophotometrically by measuring the degree of mitochondrial reduction of the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to MTT formazan as described by Mosmann (1983) . All cell viability assays were conducted on cells cultured in 96-well plates. 96-Well plates were read at 570 nm in a THERMOmax TM Microplate Reader (Molecular Devices Corp., Sunnyvale, CA).
LDH assay. Lactate dehydrogenase (LDH) enzyme activity was assayed in hepatocyte homogenates and culture medium to determine plasma membrane integrity. LDH enzyme activity in primary hepatocytes was determined using a DuPont ACA V discrete clinical analyzer (DuPont, Huffman Estates, IL). Measurements of LDH enzymatic activity were monitored at 37°C by reflectance spectrophotometry at 340 nm. The change in absorbance at 340 nm due to the formation of reduced nicotinamide adenine dinucleotide (NADH) is proportional to the rate of product formed, and, hence, enzymatic activity. The enzyme activities determined in medium were expressed as International Units (U) of Biochemistry (conversion of 1 mmol of substrate to product at 37°C per minute) per liter and reported as a percentage of total LDH (intracellular plus medium) content.
Protein assay. Cell protein content in plated cultures was determined by the Lowry method (Lowry et al., 1951) , using the BCA Protein Assay Kit (PIERCE, Rockford, IL). Cell sonicates (25 ml) were diluted 1:4 with DPBS. Aliquots (10 ml) of diluted cell sonicates and BCA assay kit reagent (200 ml) were placed in a 96-well plate and read spectrophotometrically at a wavelength of 562 nm in a THERMOmax Microplate Reader. Concentrations were expressed as mg protein/ml of original lysate.
Effective Concentration 50% (EC 50 ) Determinations
In order to evaluate the effect of BSA on Cd 2ϩ toxicity, the Cd 2ϩ exposureresponse relationship was evaluated in the presence or absence of BSA. Primary rat hepatocytes were seeded into rat tail collagen-coated 96-well culture plates and allowed to attach for 3 h. Following the 21-h recovery period, primary hepatocyte cultures were exposed to Cd 2ϩ in TGS buffer lacking BSA (1.8 to 18 M Cd 2ϩ ) or containing 600 M BSA (18 to 320 M Cd 2ϩ ) for 1 h at 37°C. Cell viability was evaluated by the MTT assay at two time points: (1) immediately after the Cd 2ϩ treatment, and (2) 23 h after the 1-h exposure. Exposure-response curves, expressed as percent of control optical density, were generated using SigmaPlot TM graphics package (Jandel Scientific, San Rafael, CA). Cadmium EC 50 values were determined by nonlinear regression analysis of exposure-response curves, using SigmaStat TM statistical package (Jandel Scientific, San Rafael, CA).
Binding Studies
Cadmium-BSA binding studies were conducted in TGS buffer containing 600 M BSA spiked with stable Cd 2ϩ (32 to 8000 M) and 109 Cd 2ϩ (0.4 20 DELRASO ET AL.
Ci/ml). Samples were incubated at 37°C for 1 h, and aliquots of each Cd 2ϩ /BSA solution (450 l) were centrifuged in Centrifree microseparation devices (Amicon, Inc., Beverly, MA), using a 33°fixed-angle rotor at 37°C for 15 min at 2000 g in an RC-5B centrifuge (Sorvall, Newtown, CT). Aliquots of the Cd 2ϩ /BSA solutions and their respective ultrafiltrates were counted for 5 min, using a Cobra Quantum gamma counter (Packard, Meriden, CT). The binding of Cd 2ϩ to the plastic microseparation devices was minimized by treating the sample reservoirs and filtrate cups with a 5% (wt/vol) solution of cetyltrimethylammonium bromide (CTAB; Aldrich, Milwaukee, WI) overnight at room temperature.
Binding data were analyzed by Scatchard analysis (Scatchard, 1949) , where the ratio of bound to free Cd 2ϩ is plotted versus the bound Cd 2ϩ concentration. Empirical fitting of the data provide estimates of the binding affinity (expressed as the dissociation constant [K d M] and the capacity [n: number of binding sites per molecule of BSA]).
Cadmium Uptake Studies
Following the 21-h recovery period, hepatocytes cultured in 6-well plates were exposed to Cd 2ϩ in TGS buffer lacking BSA (0.42 to 180 M Cd 2ϩ ) or containing 600 M BSA (32 to 1000 M Cd 2ϩ ) at 37°C. Concentration ranges for Cd 2ϩ uptake studies were based on acute cytotoxicity. Concentrations of Cd 2ϩ resulting in greater than 10% leakage of the total intracellular LDH immediately following a 1-h exposure were not used. To determine Cd 2ϩ uptake rates, 1.0 ml of Cd 2ϩ -containing exposure buffer radiolabeled with 109 Cd 2ϩ (30. 4 Ci/ml TGS buffer) was placed in each well and the cells incubated at 37°C. At specific time points, from 15 s to 60 min, radiolabeled TGS buffer was removed from each well and the wells were washed rapidly two times with ice cold phosphate-buffered saline (PBS). Following PBS washes, cells were solubilized by adding 1 ml of 0.2 N NaOH/0.2% SDS solution to each well. After removing a 25 l aliquot for protein determination, the amount of incorporated radiolabeled metal was determined by gamma spectrometry. Data were converted to nmol Cd 2ϩ /ml of lysate, using the specific activity of the exposure buffer as determined for each dosing solution, and normalized by dividing by the protein concentration (mg protein/ml cell lysate). Data are expressed as nmol Cd 2ϩ /mg cellular protein.
Uptake Rate Analysis
At specific time points up to 60 min after the addition of Cd 2ϩ , the amount of radiolabeled Cd 2ϩ associated with hepatocytes was determined. Initially, the total amount of Cd 2ϩ associated with cells (nmol/mg cell protein) was plotted versus time. The data suggested that two uptake components are active; one resulted in a rapid uptake and equilibration within the first minute (Component I) and the second in a slower linear process that occurred throughout the 1-h study (Component II). For each separate experiment, cadmium uptake rates associated with Component II (R II : nmol/min/mg cell protein) were determined from the slopes obtained from linear regression analysis of Cd 2ϩ uptake (nmol/mg cell protein) from 15 to 60 min using SigmaPlot TM ( Fig. 2A ). The amount of Cd 2ϩ accumulated via Component I (Cd I , rapidly internalized and cell membrane associated) at a particular time point (T) was calculated by subtracting Component II (Cd II ) from the total Cd 2ϩ (Cd Tot ) accumulation curve ( Fig. 2B ) according to the following equation,
where Cd I (T) ϭ amount of Cd accumulated via Component I at time T; Cd Tot (T) ϭ amount of total Cd at time T; Cd II (T) ϭ amount of Cd accumulated via Component II at time T; R II ϭ rate of Cd transport via Component II. The uptake rate for Component I was too rapid to calculate from these data. Therefore, the data for Component I were summarized by plotting the mean Ϯ SD of the plateau value for Cd 2ϩ accumulated via Component I versus Cd 2ϩ concentration. The concentration dependence of Component II was summarized by plotting the mean Ϯ SD of the uptake rate (nmol/min/mg cell protein) via Component II versus Cd 2ϩ concentration.
Statistics. Differences of means were compared by a one-way analysis of variance (ANOVA). Means found to be significant by ANOVA were compared using a Student-Newman-Keuls pairwise multiple comparison procedure with Type I error level held at p Ͻ 0.05. All statistical analyses were conducted with SigmaStat TM (Jandel Scientific, San Rafael, CA).
FIG. 1.
Experimental culture and exposure schedule for isolated rat hepatocytes. Cells Plated: hepatocytes were added to culture plates in serum-free Chee culture medium containing dexamethasone (0.4 mg/ml). Change Medium: after 3 h, medium and unattached cells were removed and fresh serum-free Chee medium lacking dexamethasone and gentamicin and containing 600 M BSA was added. Begin Exposure (t ϭ 0 h): hepatocytes were exposed to cadmium acetate dissolved in 50 mM TGS buffer (lacking or containing 600 M BSA) for 1 h. End Exposure -Change Medium: dosing buffer was removed and fresh Cd 2ϩ -free Chee medium containing 600 M BSA was added (0 h postexposure). Observation (t ϭ 24 h): at 23 h postexposure, various biochemical endpoints of hepatocyte functional status were determined.
CADMIUM UPTAKE KINETICS IN HEPATOCYTES
RESULTS
Cd 2ϩ Binding Studies
Binding studies were conducted to estimate the free Cd 2ϩ concentration in the TGS exposure buffer in the presence of 600 M BSA. The free concentration of Cd 2ϩ in the TGS exposure buffer was determined by ultrafiltration, from which data indicated that 94% or greater of the Cd 2ϩ in solution was bound to BSA at Cd 2ϩ concentrations up to 1000 M. Further increases in Cd 2ϩ concentrations above 1000 M in the presence of 600 M BSA were found to result in dramatic increases in free Cd 2ϩ concentrations (Fig. 3 ). Scatchard analysis of the Cd 2ϩ binding data (32 to 1000 M) was found to be linear with an abscissa intercept of approximately 2.0 (Fig. 4) . This result suggests that BSA contains two high-affinity binding sites for Cd 2ϩ per molecule of BSA. Scatchard analysis also indicated a dissociation constant (K d ) of 15.2 M for the BSA-Cd 2ϩ complex. At concentrations of Cd 2ϩ greater than 1000 M, the binding data indicate the presence of low affinity, nonspecific binding.
Cd 2ϩ Exposure-Response Relationship
The presence of BSA (600 M) in the TGS exposure buffer was found to have a significant effect on the Cd 2ϩ exposureresponse relationship in rat hepatocytes (Fig. 5A) . The expo- sure-response curve was shifted to the right when BSA was included in the TGS exposure buffer resulting in a significantly greater than 4-fold increase in the Cd 2ϩ EC 50 concentration when compared to exposures in TGS buffer lacking BSA. However, when the free Cd 2ϩ concentration present in TGS buffer containing BSA was used to calculate the EC 50 , an approximately 62-fold reduction in the Cd 2ϩ EC 50 concentration in the presence of BSA was observed (Fig. 5B) . Based on the free Cd 2ϩ concentration as a measure of exposure, Cd 2ϩ toxicity appeared to be enhanced in the presence of BSA by a factor of 14-fold, i.e., the EC 50 is shifted to the left in the presence of BSA, relative to that in the absence of BSA.
To determine whether the presence of BSA in the medium altered the basal state of hepatocytes and thus modulated cellular responses to Cd 2ϩ -induced toxicity, the total cellular Cd 2ϩ dose at the end of the 1-h exposure was investigated as the dose metric. The resulting dose-response relationships under the two experimental conditions (ϩ/-BSA) were observed to be similar using this dose metric (Fig. 6) . The calculated EC 50s in the presence and absence of BSA were 1.09 Ϯ 0.07 and 1.15 Ϯ 0.03 nmol/mg cellular protein, respectively.
Cd 2ϩ Uptake Kinetics
The presence of BSA in the TGS exposure buffer was also found to have a significant effect on the kinetics of Cd 2ϩ uptake. Rat hepatocytes were exposed to a range of Cd 2ϩ concentrations from 1 to 80 M in TGS buffer lacking BSA and the uptake kinetics are illustrated in Figure 7 ; note, only Cd exposures at concentrations above 80 M in the absence of BSA. Uptake was characterized by an initial rapid increase within the first 15 s, followed by a plateau phase representing cell-associated Cd 2ϩ (Component I: highlighted in Fig. 7B ) and a slower linear Cd 2ϩ uptake occurring throughout the 60-min study (Component II). Cadmium uptake rates for Component II were derived from the slope of the linear portion of the Component II Cd 2ϩ uptake between 15 and 60 min and were found to increase with dose.
Exposure of rat hepatocytes to a range of Cd 2ϩ concentrations from 32 to 1000 M in TGS buffer containing 600 M BSA, corresponding to free Cd 2ϩ concentrations from approximately 1 to 60 M, also indicated a dose-dependent, twocomponent accumulation (Fig. 8) . Based on the LDH leakage assay, significant toxicity (Ͼ10% LDH leakage) was observed at the end of the 1-h exposure of rat hepatocytes to Cd 2ϩ concentrations exceeding 1000 M in TGS buffer containing 600 M BSA. Therefore, higher concentrations were not used in kinetic studies. (B) . The second, Component II, is characterized as a slower linear uptake occurring from 15 to 60 min. Data points are plotted as the mean Ϯ SD (n ϭ 4).
FIG. 6. Effect of BSA on Cd
2ϩ dose-response relationships using total cellular Cd 2ϩ as the dose metric. Hepatocyte cultures were exposed as described in Figure 5 . MTT responses are plotted versus the total cellular Cd 2ϩ (nmol/mg protein). The calculated EC 50s , using the logistic function fitted by nonlinear regression analysis of the data derived from Cd 2ϩ exposures in the presence (dashed line) and absence (solid line) of BSA, were not found to be significantly different. 24 DELRASO ET AL. i.e., Component I plateau levels and Component II uptake rates were greater in the presence than in the absence of BSA (Figs.  9B and 10B, respectively) .
The rapid accumulation of Cd 2ϩ via Component I suggested that the possible mechanism involved may be membrane binding of Cd 2ϩ to the outer surface of hepatocytes. To test this hypothesis, the effects of an ethylene glycol-bis(␤-aminoethyl ether) tetraacetic acid (EGTA) wash on Cd 2ϩ uptake kinetics Table 1 . The EGTA wash significantly reduced the plateau levels for Component I (by approximately 90%), but had no effect on the Component II rate.
Analysis of Figure 10B , showing the nonlinear kinetic relationship between free Cd 2ϩ concentration and rate of Component II uptake, indicated that more than one transport process was involved. Component II Cd 2ϩ transport was observed to consist of both an unsaturable (linear) and a saturable (nonlinear) kinetic process. The influence of these two processes on Component II uptake (R II : nmol/min/mg) can be calculated according to the following equation,
where P (l/min/mg) is the linear transport rate constant, C M-Free (M) is the free Cd 2ϩ concentration in medium, T MAX (mol/ min/mg) is the maximum transport rate for the saturable process and K T (M) is the concentration at which the saturable transport rate is at half maximum velocity. The P term in the above equation is related to the unsaturable kinetic process of Cd 2ϩ uptake, and the T MAX and K T terms are related to the saturable kinetic process of Cd 2ϩ uptake. The kinetic parameters for the two transport processes were estimated by fitting Equation 2 to the experimental data. The results are presented in Table 2 . The unsaturable kinetic rate constant for Cd 5.10 Ϯ 3.27
Note. P, linear transport rate constant; T MAX , maximum transport rate for the saturable transport process; K T , concentration at half maximum saturable rate. * Significant vs. -Alb (p Յ 0.05).
transport, P, in the presence of BSA, was significantly greater relative to that in the absence of BSA (Table 2 ). In the case of Component II Cd 2ϩ , uptake differences in K T and T MAX between treatments are not statistically significant.
DISCUSSION
The use of in vitro data for the development of BBK models for supporting risk assessment will require that in vitro data be obtained under physiologically relevant conditions. Therefore, one of the goals of the present study was to conduct in vitro Cd 2ϩ toxicity and kinetic studies under conditions that more closely resemble Cd 2ϩ exposure of target organs via the blood. Albumin, at a physiological concentration of approximately 600 M, is a critical macromolecule in plasma and plays an important role in binding and transporting Zn 2ϩ and other metals. In fact, Cd 2ϩ has a high affinity for anionic and sulfhydryl groups on albumin and Mt (Nordberg et al., 1985) and circulates in the blood primarily bound to these macromolecules (Foulkes and Blanck, 1990; Roberts and Clark, 1988) . In the case of Zn, 98% of the exchangeable fraction of serum Zn 2ϩ is bound to albumin (Giroux and Henkin, 1972) . Although there are numerous potential Zn 2ϩ binding sites on albumin, the Zn 2ϩ concentration in blood does not appear to exceed the albumin concentration under physiological conditions. This suggests that only one high-affinity Zn 2ϩ binding site on albumin is occupied under physiological conditions. Previous studies have shown that Cd 2ϩ can bind to rat and human plasma albumin (Goumakos et al., 1991; Nordberg and Nordberg, 1987; Suzuki et al., 1986) . The Scatchard analysis of equilibrium dialysis data in a previous study has indicated two high-affinity Cd 2ϩ binding sites and one high-affinity Zn 2ϩ binding site on human and canine albumin (Goumakos et al., 1991) . In the present study, Scatchard analysis of Cd 2ϩ -BSA binding data agreed with the previous binding studies and indicated two high affinity Cd 2ϩ binding sites on BSA. Scatchard analysis also indicated a dissociation constant of 15.2 M for the BSA-Cd 2ϩ complex. This is lower than a previously reported dissociation constant of 38 M for a human albumin-Cd 2ϩ complex (Aoki and Suzuki, 1987) . These data suggest that although different species of albumin appear to have similar numbers of binding sites, they do not appear to have the same binding affinity for Cd 2ϩ . Thus, when using in vitro binding in in vivo BBK models it may be necessary to utilize binding parameters specifically evaluated for the albumin species of interest.
Data presented in the present study indicated that transport of Cd 2ϩ into rat hepatocytes occurred as a two-component process that is hypothesized to involve binding to the plasma membrane and internalization. The proposed first component (Component I) was observed to be rapid reaching a steady state in less than one minute. We hypothesized that failure to derive a rate for this rapid component of Cd 2ϩ uptake was due to rapid equilibrium binding of Cd 2ϩ to the outer surface of the plasma membrane. This component, unlike Component II, was found to be sensitive to washes containing the metal chelator EGTA. This additional finding supports the notion that Component I Cd 2ϩ uptake was associated with surface binding. In the present study, the slower uptake phase (Component II) of Cd 2ϩ correlated well with previously reported studies of Cd 2ϩ uptake in rat hepatocytes. In fact, the Component II uptake rates obtained in the present study in primary hepatocytes exposed to Cd 2ϩ in TGS buffer lacking albumin were similar to that obtained by in primary hepatocytes exposed to Cd 2ϩ in saline. Furthermore, Failla et al. (1979) have shown that the quantity of Cd 2ϩ accumulated by hepatocytes is directly proportional to both the level of metal and the duration of the incubation. These authors showed that Cd 2ϩ accumulated linearly by this slower phase of uptake for 7 to 8 h in monolayers of primary hepatocytes.
In vitro studies have indicated that cellular Cd 2ϩ and other chemical uptake and toxicity are reduced in the presence of albumin (Frazier, 1995; Gulden et al. 2002; Klug et al., 1988; Seibert et al., 2002) . Frazier (1995) has shown that as the albumin concentration increases the Cd 2ϩ exposure-response curve shifts to the right, indicating an apparent increased resistance to Cd 2ϩ toxicity. In the present study, the exposure of rat hepatocytes to Cd 2ϩ in solutions containing physiological albumin (600 M) also resulted in a shift in the exposureresponse curve to the right when compared to similar Cd 2ϩ exposures in the absence of albumin. Therefore, the observed Cd 2ϩ EC 50 , determined under more physiological conditions, was found to be 65.5 Ϯ 2.4 M. This value was 4-fold greater than that of the EC 50 observed under BSA-free conditions (14.3 Ϯ 3.9 M). However, when this EC 50 was recalculated, using the amount of free Cd 2ϩ in the BSA-containing exposure buffer as the dose metric, the EC 50 was reduced by a factor of 62 to 1.05 Ϯ 0.36 M, an approximate 14-fold reduction compared to the EC 50 observed under BSA-free conditions. Interestingly, when these exposure-response curves were plotted using intracellular Cd 2ϩ (nmol/mg) as the dose metric, instead of the Cd 2ϩ concentration in the exposure buffer, no significant difference in the calculated EC 50 was observed. In addition, when the slopes of the Cd 2ϩ exposure-response curve derived from Cd 2ϩ -exposed rat hepatocytes in the presence and absence of BSA were observed they were similar. This suggests that the mechanism of toxicity was not affected by the presence of BSA. These findings indicate that the protective effect of albumin resulted from a reduction of the Cd 2ϩ uptake and was not due to some direct beneficial effect of albumin on hepatocytes. This is supported by the recent work of Gulden et al. (2002) , where it was demonstrated that albumin had no other effect than to bind organochlorine pesticides and chlorophenols in vitro, and that cytotoxicity was based solely on the free concentration of these chemicals. The data further suggest that significant Cd 2ϩ -induced hepatotoxicity, regardless of exposure conditions, occurs when an apparent 27 CADMIUM UPTAKE KINETICS IN HEPATOCYTES intracellular threshold of approximately 0.7 nmol/mg is exceeded.
Previous ex vivo studies investigating hepatic Cd 2ϩ transport using isolated perfused rat liver are consistent with the hypothesis that Cd 2ϩ uptake into the liver occurs via a combination of simple diffusion and a carrier-mediated process Kingsley, 1976, 1977; Kingsley and Frazier, 1979) . A temperature-sensitive, facilitated-carrier transport mechanism operating in conjunction with passive diffusion in the uptake of Cd 2ϩ and Zn 2ϩ has also been reported in other systems (Bobilya et al., 1992; Failla and Cousins, 1978; Failla et al., 1979; Frazier, 1981; Klaassen, 1980, 1981) . In the present study, the rate of Cd 2ϩ transport via Component II was non linearly related to the concentration of free Cd 2ϩ in the exposure medium (see Fig. 10B ). This result suggests that more than one transport process was involved in Cd 2ϩ uptake and is consistent with the previous studies on Cd 2ϩ transport mentioned above. As noted above, when the exposure concentration of Cd 2ϩ is expressed as the calculated free Cd 2ϩ based on the binding studies, the Component II Cd 2ϩ uptake rate in the presence of BSA was increased when compared to the uptake rate at similar free Cd ϩ2 exposure concentrations in the absence of BSA. We have hypothesized that this behavior may have resulted from diffusion-limited, nonequilibrium conditions occurring near the cell surface that in effect results in higher free Cd 2ϩ concentrations at the cell surface in the presence of BSA (Fig. 11) . Support for this hypothesis is found in the work of Weisiger et al. (1991) . They expanded a sinusoidal transport model to investigate hepatic uptake of protein-bound ligands.
These authors found that an earlier standard sinusoidal transport model (Baker and Bradley, 1966; Goresky et al., 1973) failed to fit their biological data, which showed increased uptake rates in the presence of increasing albumin concentrations for equivalent free concentrations of an anionic ligand (oleate). They determined that the standard model was deficient because it did not consider the presence of diffusion through an unstirred water layer. This layer is always found adjacent to membranes and often can be a major factor in determining the uptake rate in experimental systems (Barry and Diamond, 1984; Weisiger et al., 1989) . In an extension of the standard sinusoidal transport model, Bass and Pond (1988) incorporated an unstirred fluid layer near the cell surface across which ligand must diffuse to reach the cell. In their model, when the free concentration of the ligand in the bulk medium is equal in the presence and absence of albumin, the free concentration of ligand near the transporting membrane is higher in the presence of albumin. This occurs because free ligand near the membrane can arise both from diffusion of free ligand directly through the unstirred layer, and also from release of bound ligand that has diffused to the membrane surface. Thus, in this situation, the binding between ligand and albumin is not in equilibrium near the membrane surface. The extra free ligand near the membrane in the presence of albumin essentially occurs because there is enhanced transport of ligand through the unstirred layer, namely, the normal diffusion of free ligand plus the additional diffusion of bound ligand. Although the diffusion of bound ligand is fairly slow, due to the lower diffusion constant of albumin relative to free ligand, the potentially high concentration of bound ligand in the bulk medium can provide a significant increase to net delivery of free ligand to the membrane surface. It is the concentration of free ligand near the membrane surface that determines the rate of transport through the membrane. This type of model was found to explain the albumin dependence of the kinetic data of Weisiger et al. (1991) and is consistent with our Cd 2ϩ uptake data in the presence and absence of albumin.
An additional piece of evidence that suggests that the concentration of free Cd 2ϩ in the presence of BSA is higher at the surface of the hepatocytes relative to the concentration in the absence of BSA, is the increase in Component I Cd 2ϩ accumulation. If Component I is, in part, a measure of the surface binding of Cd 2ϩ to the plasma membrane, then the increase in Component I in the presence of BSA is indicative of a higher free Cd 2ϩ concentration at the surface. This observation supports the proposed explanation of the albumin effect.
Furthermore, the results of the analysis of the concentration dependence of Component II Cd 2ϩ uptake is also consistent with the unstirred layer hypothesis. Given the existence of the unstirred layer, in the presence of BSA, the linear transport rate constant (P) should increase and the concentration at half maximum saturable transport (K T ) should decrease. The data indicate that P did increase significantly. On the other hand, while there was a trend for K T to decrease, the difference is not statistically significant. Unfortunately, the experimental design did not allow for a good statistical comparison of K T between treatments. Additional uptake experiments at free Cd 2ϩ concentrations near the K T would be required to resolve this issue.
In summary, our data indicated that the exposure of primary rat hepatocytes to Cd 2ϩ in the presence of physiological concentrations of BSA (600 M) altered the cadmium doseresponse relationship, indicating less toxicity when compared to Cd 2ϩ exposures in the absence of BSA. However, the Cd 2ϩ dose-response relationships were similar when viability was plotted against the amount of Cd 2ϩ internalized by rat hepatocytes, independent of the presence of BSA. These data suggest that the apparent reduced hepatotoxicity is due to the binding of Cd 2ϩ to BSA in the exposure buffer with a consequent reduction in the concentration of free Cd 2ϩ available for transport into the hepatocytes. The present study also indicates that the internalization rate of Cd 2ϩ via Component II in rat hepatocytes exposed in the presence of BSA was enhanced compared to the internalization rate in the absence of BSA at corresponding free Cd 2ϩ concentrations in the bulk medium. Taken together, our data suggest that the presence of BSA alters the rate of Cd 2ϩ uptake, but not the dose-response relationships when the internal dose is used as the dose metric. We hypothesize that the effects of BSA on kinetics result from diffusion-limited, nonequilibrium conditions occurring near the cell surface, and resulting in higher free Cd 2ϩ concentrations at the cell surface. This hypothesis is consistent with the hepatic-uptake model proposed by Bass and Pond (1988) that incorporated this feature into their model.
